April 02, 2025

HPV Testing Guidelines Updated for Head and Neck Carcinomas

New evidence expands recommendations for sinonasal squamous cell carcinoma and standardizes p16 immunohistochemistry interpretation.

Conexiant

March 31, 2025

Tariff Threat: Drugs Could Cost U.S. $750M More

New research reveals 25% tariffs on Canadian pharmaceuticals would impact critical medications, strain supply chains, and potentially increase costs—with 28 drugs having no alternative suppliers.

Conexiant

March 31, 2025

95% of New Drugs Lack Lactation Safety Data, Study Finds

Only 5% of new drug approvals included human lactation data, according to researchers calling for improved lactation pharmacokinetics research for breastfeeding women.

Conexiant

March 31, 2025

Can Diet Changes Reduce Endometriosis Pain?

New survey reveals specific dietary changes and supplements are associated with reduced chronic pain symptoms in individuals with endometriosis.

Conexiant

March 27, 2025

New Review Explores Hormone Therapy for Mood Disorders

Women with PMDD, PND, and menopausal depression may benefit from hormone therapy, suggest investigators.

Conexiant

March 24, 2025

HS Guidelines for Special Populations

"These guidelines address the unique needs of diverse groups typically underrepresented in clinical trials, and highlight the importance of a multidisciplinary approach."

Conexiant

March 19, 2025

Study: Sex Differences in Physician Suicide

Researchers found that female physicians had a significantly higher suicide risk than female nonphysicians.

Conexiant

March 18, 2025

U.S. Fertility Rates Continue Decline; Age of Mothers Shifts

Maternal age distribution shifts dramatically as overall birth rates continue a 30-year decline, with women younger than 30 now accounting for less than half of all births, and an increase of older mothers.

Conexiant

March 14, 2025

Oral Male Contraceptive Shows Promise

New nonhormonal compound YCT-529 effectively and reversibly inhibits fertility in mice and nonhuman primates, and may offer potential breakthrough in male birth control options

Conexiant